Thursday, November 2, 2023
Times are in pacific standard time zone.


2:30 PM Registration, Exhibits and Light Snacks
2:50 PM Welcome Remarks

SESSION 1: AI Diagnostics
3:00 PM GA progression with AI – Ursula Schmidt-Erfurth, MD
3:05 PM Diabetic retinopathy screening – Jennifer Lim, MD
3:10 PM AI in vitreoretinal Surgery Yannek I. Leiderman, MD
3:15 PM Panel Discussion
Moderators: Theodore Leng, MD, FACS and Daniel Ting, MBBS (Hons), M Med(Ophth)
Panelists: Yannek I. Leiderman, MD, Jennifer Lim, MD, Ursula Schmidt-Erfurth, MD, Yasir J. Sepah, MBBS

SESSION 2: Is Complement Inhibition Overrated?
3:30 PM Inflammation: is it real and will it harm patients – Sunil Srivastava, MD
3:35 PM Real world experience with complement inhibition – Dante Pieramici, MD
3:40 PM Emerging complement targets and delivery – Peter Kaiser, MD
3:45 PM Safety reporting for ocular therapies – Judy Kim. MD
3:50 PM Panel Discussion
Moderators: Diana Do, MD and Eleonora M. Lad, MD, PhD
Panelists: Peter Kaiser, MD, Judy Kim, MD, Sunil Srivastava, MD, Dante Pieramici, MD, Ehsan Rahimy, MD, Demetrios Vavvas, MD,

SESSION 3: New Targets? Better Drugs? Better Delivery?
4:05 PM Non-intravitreal delivery – Michael Singer, MD
4:10 PM Just an eye drop: Topical delivery technologies – Arshad M. Khanani, MD
4:15 PM Biosimilars in today’s practice enviroment – David M. Brown, MD
4:20 PM Economics of biosimilars: The good and bad – Ravi Parikh, MD, PhD
4:25 PM Panel Discussion: Biosimilars are here, now what?
Moderators: Baruch D. Kuppermann and Prithvi Mruthyunjaya MD, MHS
Panelists: David M. Brown, Arshad M. Khanani, MD, Raja Narayanan, MD, Ravi Parikh, MD, Michael Singer, MD

4:40 PM Break, Exhibits and Dinner

SESSION 4: Young Innovators Forum (NON-CE)
5:10 PM The academic career: Feeding innovation into industry – Cynthia Toth, MD
5:15 PM Climbing the ladder in Industry: Where to go next – Thomas Ciulla, MD
5:20 PM Is there still a role to be a surgical innovator? – Ramin Tadayoni, MD
5:25 PM Panel Discussion: Defining a career outside the retina clinic and operating room
Moderators: Stephen Smith, MD and Darius M. Moshfeghi, MD
Panelists: Thomas Ciulla, MD, Cynthia Toth, MD, Ramin Tadayoni, MD, Audina M. Berrocal, MD, Kimberly A. Drenser, MD, PhD

SESSION 5: Impending Innovations in Angiogenesis (NON-CE)
5:45 PM A novel clinical trial design for the study of intermediate AMD using the oral Connexin43 inhibitor tonabersat – Philip Rosenfeld, MD
5:50 PM Non-VEGF strategies: Promise or bust? – David Boyer, MD
5:55 PM Gene therapy solutions – Lejla Vajzovic, MD
6:00 PM Clinical trial design for exudative diseases – Wiley Chambers, MD
6:05 PM Panel Discussion: Challenges in future clinical trial design
Moderator: Robert Bhisitkul, MD, PhD and Quan Dong Nguyen, MD, MSc
Panelists: David Boyer, MD, Wiley Chambers, MD, Lejla Vajzovic, MD, Philip J Rosenfeld, MD, PhD, Erin C. Henry, PhD, Riad Sherif, MD, Christine Kay, MD

6:30 PM Dessert and Closing Reception/Dinner